GlaxoSmithKline PLC at UBS Global Consumer & Retail Conference (Virtual) Transcript

Mar 09, 2022 / 04:00PM GMT
Guillaume Gerard Vincent Delmas - UBS Investment Bank, Research Division - Analyst

Hello, everyone, and welcome to this Haleon fireside chat. My name is Guillaume Delmas. I head the European food and HPC team here at UBS. So today, absolutely delighted to have with us Haleon's Chief Financial Officer, Tobias Hestler. Tobias, thank you for your time today. Plenty to discuss. As you know, Haleon had its Capital Markets Day last week and the planned demerger should occur in July of this year.

So for the purpose of this fireside chat, I thought I would mostly focus on your medium-term prospects, both at the group level, but also for each of your 3 divisions. And then maybe spend the last 5 to 10 minutes focusing more on short-term priorities, potentially challenges.

Questions and Answers:

Guillaume Gerard Vincent Delmas - UBS Investment Bank, Research Division - Analyst

(Operator Instructions) And with that, let's start. So Tobias, on your medium-term organic sales growth ambitions, you are targeting 4% to 6%. Your category growth, you estimate is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot